Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
‘A historic victory’ : our panel reacts to Zohran Mamdani’s triumph | Panel
5/11/2025
Radiohead review – bards of the apocalypse return for a brutal bacchanal
5/11/2025
Fixing Britain’s worklessness crisis will cost employers £6bn a year, report says
5/11/2025
Othello review – David Harewood makes a commanding return to landmark role
5/11/2025
‘Young people can come in and have life-changing moments’ : Gus Casely-Hayford on V&A East, a new museum for Gen Z
5/11/2025
Soy, oat, almond, rice : which alternative milk is healthiest ?
4/11/2025